Literature DB >> 19466904

Quantitative analysis and design of a spray aerosol inhaler. Part 1: effects of dilution air inlets and flow paths.

P Worth Longest1, Michael Hindle.   

Abstract

BACKGROUND: The objective of this study was to evaluate the effects of modifying inhaler design variables on aerosol drug deposition within the mouthpiece for a representative spray system using a quantitative analysis and design approach.
METHODS: Capillary aerosol generation (CAG) was selected as a model spray aerosol system in conjunction with four prototype inhaler body and mouthpiece combinations. In vitro experiments were used to determine drug deposition in the mouthpiece and induction port. Validated computational fluid dynamics (CFD) simulations were implemented to establish relationships between design variables, transport characteristics, and aerosol drug deposition.
RESULTS: Results of this study indicated that both the size of the upstream dilution air inlets and the flow pathway configuration near the spray nozzle significantly influenced aerosol transport and deposition. CFD results showed that the primary transport characteristics associated with drug deposition were turbulence intensity and the effective diameter of the mouthpiece. Strong quantitative correlations were developed between the identified transport characteristics and mouthpiece drug deposition.
CONCLUSIONS: Based on quantitative analysis and design, turbulence intensity and effective mouthpiece diameter were identified as key transport characteristics within the design space that directly influenced aerosol deposition and may be used to predict and optimize drug delivery to the patient.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19466904     DOI: 10.1089/jamp.2008.0739

Source DB:  PubMed          Journal:  J Aerosol Med Pulm Drug Deliv        ISSN: 1941-2711            Impact factor:   2.849


  16 in total

1.  Comparing MDI and DPI aerosol deposition using in vitro experiments and a new stochastic individual path (SIP) model of the conducting airways.

Authors:  P Worth Longest; Geng Tian; Ross L Walenga; Michael Hindle
Journal:  Pharm Res       Date:  2012-06       Impact factor: 4.200

2.  Generating Charged Pharmaceutical Aerosols Intended to Improve Targeted Drug Delivery in Ventilated Infants.

Authors:  Landon Holbrook; Michael Hindle; P Worth Longest
Journal:  J Aerosol Sci       Date:  2015-10-01       Impact factor: 3.433

Review 3.  Devices for Improved Delivery of Nebulized Pharmaceutical Aerosols to the Lungs.

Authors:  Worth Longest; Benjamin Spence; Michael Hindle
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2019-07-09       Impact factor: 2.849

4.  Development of a High-Flow Nasal Cannula and Pharmaceutical Aerosol Combination Device.

Authors:  Benjamin M Spence; Worth Longest; Xiangyin Wei; Sneha Dhapare; Michael Hindle
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2019-03-11       Impact factor: 2.849

5.  High-Efficiency Nose-to-Lung Aerosol Delivery in an Infant: Development of a Validated Computational Fluid Dynamics Method.

Authors:  Karl Bass; Susan Boc; Michael Hindle; Kelley Dodson; Worth Longest
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2018-12-15       Impact factor: 2.849

Review 6.  In silico models of aerosol delivery to the respiratory tract - development and applications.

Authors:  P Worth Longest; Landon T Holbrook
Journal:  Adv Drug Deliv Rev       Date:  2011-05-27       Impact factor: 15.470

Review 7.  Use of computational fluid dynamics deposition modeling in respiratory drug delivery.

Authors:  P Worth Longest; Karl Bass; Rabijit Dutta; Vijaya Rani; Morgan L Thomas; Ahmad El-Achwah; Michael Hindle
Journal:  Expert Opin Drug Deliv       Date:  2018-12-10       Impact factor: 6.648

8.  Improving pharmaceutical aerosol delivery during noninvasive ventilation: effects of streamlined components.

Authors:  P Worth Longest; Laleh Golshahi; Michael Hindle
Journal:  Ann Biomed Eng       Date:  2013-02-20       Impact factor: 3.934

9.  Development of an Inline Dry Powder Inhaler That Requires Low Air Volume.

Authors:  Dale Farkas; Michael Hindle; P Worth Longest
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2017-12-20       Impact factor: 2.849

10.  Aerodynamic factors responsible for the deaggregation of carrier-free drug powders to form micrometer and submicrometer aerosols.

Authors:  P Worth Longest; Yoen-Ju Son; Landon Holbrook; Michael Hindle
Journal:  Pharm Res       Date:  2013-03-08       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.